Dark Forest Capital Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Other funds holding REGN
Dark Forest Capital Management's REGN Position: Q2 2026 in Review
Dark Forest Capital Management increased its Regeneron Pharmaceuticals (REGN) stake by 452% in Q2 2026, buying an estimated $1.42M and bringing the position to 2,547 shares worth $1.59M. The position accounts for 0.1% of the portfolio, ranked #354.
Dark Forest Capital Management first reported a position in REGN in Q2 2023 and has held it in 6 quarters since. The position peaked at $3.41M in Q3 2025. 1,332 funds tracked by Wall St. Rank hold REGN as of Q2 2026.
- Dark Forest Capital Management held 2,547 shares of Regeneron Pharmaceuticals worth $1.59M as of Q2 2026.
- Dark Forest Capital Management bought 2,086 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $1.42M.
- Regeneron Pharmaceuticals made up 0.1% of Dark Forest Capital Management's portfolio in Q2 2026, its #354 holding.
- Dark Forest Capital Management first reported a position in Regeneron Pharmaceuticals in Q2 2023 and has held it in 6 quarters since.
- Dark Forest Capital Management's Regeneron Pharmaceuticals position peaked at $3.41M in Q3 2025.
- 1,332 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.
Based on Dark Forest Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.